Despite the long history of nanoparticulate calcium phosphate (CaP) as a
non-viral transfection agent, there has been limited success in attempts to
optimize its properties for transfection comparable in efficiency to that of
viral vectors. Here we focus on the optimization of: (a) CaP nanoparticle
precipitation conditions, predominantly supersaturation and Ca/P molar ratios;
(b) transfection conditions, mainly the concentrations of the carrier and
plasmid DNA; (c) the presence of surface additives, including citrate anion and
cationic poly(L-lysine) (PLL). CaP nanoparticles significantly improved
transfection with plasmid DNA encoding enhanced green fluorescent protein (eGFP)
in pre-osteoblastic MC3T3-E1 cells compared to a commercial non-viral carrier.
At the same time they elicited significantly lesser cytotoxicity than the
commercial carrier. Plasmid DNA acted as a nucleation promoter, decreasing the
nucleation lag time of metastable CaP solutions and leading to a higher rate of
nucleation and a lower size of the precipitated particles. The degree of
supersaturation (DS) of 15 was found to be more optimal for transfection than
that of 12.5 or 17.5 and higher. Because CaP particles precipitated at DS 15
were spherical, while DS 17.5 and 21 yielded acicular particles, it was
concluded that spherical particle morphologies were more conducive to
transfection than the anisotropic ones. Even though the yield at DS 15 was 10
and 100 times lower than that at DS 17.5 and 21, respectively, transfection
rates were higher using CaP nanoparticle colloids prepared at DS 15 than using
those made at higher or lower DS, indicating that the right particle morphology
can outweigh the difference in the amount of the carrier, even when this
difference is close to 100x. In contrast to the commercial carrier, the
concentration of CaP-pDNA delivered to the cells was directly proportional to
the transfection rate. Osteosarcoma K7M2 cells were four times more easily
transfectable with CaP nanoparticles than the MC3T3-E1 cells. The addition of
citrate increased the transfection rate at lower concentrations; however, a
complete redispersal of CaP-pDNA nanoparticles at higher concentrations of
citrate coincided with a complete diminishment of transfection, implying the
benefits of partial aggregation of CaP nanoparticles carrying pDNA. In contrast,
PLL delayed transfection initially, but enhanced it at longer time points
(≥ 96 h), leading to the conclusion that both citrate and PLL could
exert positive effects on transfection: citrate if added at low concentrations
and PLL to extend transfection over longer periods of time.